Antibiograms and plasmids of Staphylococcus aureus and coagulase negative staphylococci isolated from different clinical sources. 1996

C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
Department of Biological Sciences, University of Lagos, Akoka, Nigeria.

OBJECTIVE To ascertain the antibiotic resistance patterns and plasmids of Staphyl coccus aureus and coagulae negative staphylococci isolated from different clinical specimens in Lagos, Nigeria. METHODS Prospective study involving the screening of specimens of blood, urine, skin and soft tissue infections, vagina, urethra, eye, ear, nose, pleural fluid and seminal fluid obtained from patients attending the Lagos University Teaching Hospital (LUTH) and Providence Hospital Diagnostic Laboratories, Lagos, Nigeria. METHODS A laboratory based study conducted in the Microbiology Unit, University of Lagos and the National Institute for Medical Research (NIMR) Lagos, Nigeria. The patients were from different communities in Lagos. METHODS A total of 200 patients that were positive for the presence of S. aureus and coagulase negative staphylococci (CONS) were employed in the study. METHODS Frequency of isolation of S. aureus and coagulase negative staphylococci (CONS) from the different clinical specimens determination of their resistance profile using standard techniques for the isolation of both organisms and the Kirby-Bauer disc diffusion method for antibiotic testing. RESULTS All the S. aureus and CONS isolates were sensitive to novobiocin and ofloxacin. Ninety eight (80 pc) of S. aureus isolates were resistant to tetracycline (Tet), 73 (60 pc) to Streptomycin (Str), and 49 (40 pc) to Chloramphenicol (Chl). All the S. aureus isolates were resistant to Penicillin (P) and only two (2 pc) and four (three pc) were resistant to Cefuroxime (Cxm) and Ceftriasone (Cro) in that order. Twenty six (21 pc) of S. aureus isolates were resistant to Methicillin. For CONS, 92 pc were resistant to Penicillin, 47 (60 pc) to streptomycin and 40 (51 pc) to tetracycline. Nineteen (24 pc) were resistant to Methicillin. Further antibiotic sensitivity results revealed the following patterns: 87 (71 pc) and 29 (36 pc) of S. aureus and CONS respectively showed P RTet"R, pattern of resistance. The resistance pattern PREryRGmRCazRCxmR was shown by only one (17 pc) of S. aureus and none (Opc) of CONS. Only 59% and four pc of S. aureus and CONS isolates showed resistance pattern ChlREryR, CazR respectively. Results of plasmid profiles showed that 48 (96 pc) of 50 S. aureus and 26 (87 pc) of 30 CONS isolates harboured one or more plasmids of molecular sizes ranging from 1.0 Kb to 19.5 Kb. Nine (19 pc) of 48 S. aureus and three (12 pc) of CONS isolates showed plasmid identity. CONCLUSIONS We assert that although isolates of S. aureus and CONS showed multiple antibiotic resistance which could be plasmid mediated, only about five pc of both organisms showed resistance pattern ChlREryRCazRTetRCxmRSxtRGmR and EryRGmRCazRCxmR and this is of chemotherapeutic importance. Both organisms, were highly sensitive to Ceftriazone, Ceforoxime and Gentamicin. The high levels of resistance of many antibiotics may be attributable to indiscriminate use or antibiotic abuse in the community.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011815 R Factors A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation. R Factor,R Plasmid,R Plasmids,Resistance Factor,Resistance Factors,Factor, R,Factor, Resistance,Factors, R,Factors, Resistance,Plasmid, R,Plasmids, R
D003030 Coagulase Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen. Staphylocoagulase,Staphylococcal Clumping Factor,Clumping Factor (Staphylococcal),Staphylococcus aureus clone pSCa2 of Coagulase,Staphylococcus aureus strain 213 of Coagulase,Staphylococcus aureus strain 8325-4 of Coagulase,Clumping Factor, Staphylococcal,Factor, Staphylococcal Clumping,Staphylococcus aureus strain 8325 4 of Coagulase
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
January 1982, Indian journal of medical sciences,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
August 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
July 1995, Plasmid,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
September 1972, Rinsho byori. The Japanese journal of clinical pathology,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
November 1998, Journal of dermatological science,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
March 1992, Plasmid,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
February 2009, Veterinary microbiology,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
October 1981, The Cornell veterinarian,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
April 2012, Mymensingh medical journal : MMJ,
C L Obi, and A E Iyiegbuniwe, and D K Olukoya, and C Babalola, and E O Igumbor, and A A Okonta
January 2010, Veterinary medicine international,
Copied contents to your clipboard!